Image-defined Risk Factors Correlate with Surgical Radicality and Local Recurrence in Patients with Neuroblastoma

被引:20
作者
Pohl, A. [1 ]
Erichsen, M. [1 ]
Stehr, M. [2 ]
Hubertus, J. [1 ]
Bergmann, F. [1 ]
Kammer, B. [3 ]
von Schweinitz, D. [1 ]
机构
[1] Dr von Hauners Childrens Hosp, Dept Pediat Surg, Lindwurmstr 4, D-80337 Munich, Germany
[2] Cnopfsche Childrens Clin, Dept Pediat Surg, Nurnberg, Germany
[3] Univ Munich, Dr von Haunersches Childrens Hosp, Inst Clin Radiol, Munich, Germany
来源
KLINISCHE PADIATRIE | 2016年 / 228卷 / 03期
关键词
neuroblastoma; outcome; image-defined risk factors; surgery; INTERNATIONAL CRITERIA; RELAPSED NEUROBLASTOMA; SURGERY; DIAGNOSIS; SURVIVAL; IMPACT; COMPLICATIONS; RESECTION; CHILDREN; THERAPY;
D O I
10.1055/s-0041-111175
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Neuroblastoma is the second most common solid pediatric tumor and the most common cancer to be detected in children younger than 12 months of age. To date, 2 different staging systems describe the extent of the disease: the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Risk Group Staging System (INRGSS). The INRGSS-system is characterized by the presence or absence of so called image-defined risk factors (IDRFs), which are described as surgical risk factors. We hypothesized that IDRFs correlate with surgical complications, surgical radicality, local recurrence and overall survival (OS). Patients and methods: Between 2003 and 2010, 102 patients had neuroblastoma surgery performed in our department. We analyzed medical records for IDRF-status and above named data. Results: 16 patients were IDRF-negative, whereas 86 patients showed one or more IDRF. Intra-or postoperative complications have been reported in 21 patients (21 %). 19 of them showed one or more IDRF and 2 patients were IDRF-negative (p = n.s.). Patients who suffered from intra-or postoperative complications demonstrated a decreased OS (p = 0.011). Statistical analysis revealed an inverse correlation between the extent of macroscopical removal and IDRF-status (p = 0.001). Furthermore, the number of IDRFs were associated with a decreased likelihood of radical tumor resection (p < 0.001). 19 patients had local recurrence; all of them were IDRF-positive (p = 0.037). Conclusions: Pediatric surgeons should consider IDRFs as a useful tool for risk assessment and therefore planning for neuroblastoma surgery.
引用
收藏
页码:118 / 123
页数:6
相关论文
共 26 条
[1]   Impact of Postoperative Complications on Overall Survival of Patients With Hepatoblastoma [J].
Becker, Kristina ;
Furch, Christiane ;
Schmid, Irene ;
von Schweinitz, Dietrich ;
Haeberle, Beate .
PEDIATRIC BLOOD & CANCER, 2015, 62 (01) :24-28
[2]   The current contributional of molecular factors to risk estimation in neuroblastoma patients [J].
Berthold, F ;
Sahin, K ;
Hero, B ;
Christiansen, H ;
Gehring, M ;
Harms, D ;
Horz, S ;
Lampert, F ;
Schwab, M ;
Terpe, J .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (12) :2092-2097
[3]   MASS-SCREENING IN JAPAN INCREASED THE DETECTION OF INFANTS WITH NEUROBLASTOMA WITHOUT A DECREASE IN CASES IN OLDER CHILDREN [J].
BESSHO, F ;
HASHIZUME, K ;
NAKAJO, T ;
KAMOSHITA, S .
JOURNAL OF PEDIATRICS, 1991, 119 (02) :237-241
[4]   Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma [J].
Bowman, LC ;
Grossmann, M ;
Rill, D ;
Brown, M ;
Zhong, WY ;
Alexander, B ;
Leimig, T ;
Coustan-Smith, E ;
Campana, D ;
Jenkins, J ;
Woods, D ;
Brenner, M .
HUMAN GENE THERAPY, 1998, 9 (09) :1303-1311
[5]   Neuroblastoma tumour genetics: clinical and biological aspects [J].
Bown, N .
JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (12) :897-910
[6]   REVISIONS OF THE INTERNATIONAL CRITERIA FOR NEUROBLASTOMA DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT [J].
BRODEUR, GM ;
PRITCHARD, J ;
BERTHOLD, F ;
CARLSEN, NLT ;
CASTEL, V ;
CASTLEBERRY, RP ;
DEBERNARDI, B ;
EVANS, AE ;
FAVROT, M ;
HEDBORG, F ;
KANEKO, M ;
KEMSHEAD, J ;
LAMPERT, F ;
LEE, REJ ;
LOOK, AT ;
PEARSON, ADJ ;
PHILIP, T ;
ROALD, B ;
SAWADA, T ;
SEEGER, RC ;
TSUCHIDA, Y ;
VOUTE, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) :1466-1477
[7]   INTERNATIONAL CRITERIA FOR DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT IN PATIENTS WITH NEURO-BLASTOMA [J].
BRODEUR, GM ;
SEEGER, RC ;
BARRETT, A ;
BERTHOLD, F ;
CASTLEBERRY, RP ;
DANGIO, G ;
DEBERNARDI, B ;
EVANS, AE ;
FAVROT, M ;
FREEMAN, AI ;
HAASE, G ;
HARTMANN, O ;
HAYES, FA ;
HELSON, L ;
KEMSHEAD, J ;
LAMPERT, F ;
NINANE, J ;
OHKAWA, H ;
PHILIP, T ;
PINKERTON, CR ;
PRITCHARD, J ;
SAWADA, T ;
SIEGEL, S ;
SMITH, EI ;
TSUCHIDA, Y ;
VOUTE, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (12) :1874-1881
[8]   The role of surgery in stage IV neuroblastoma [J].
Castel, V ;
Tovar, JA ;
Costa, E ;
Cuadros, J ;
Ruiz, A ;
Rollan, V ;
Ruiz-Jimenez, JI ;
Perez-Hernández, R ;
Cañete, A .
JOURNAL OF PEDIATRIC SURGERY, 2002, 37 (11) :1574-1578
[9]   Surgical risk factors in primary surgery for localized neuroblastoma:: The LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group [J].
Cecchetto, G ;
Mosseri, V ;
De Bernardi, B ;
Helardot, P ;
Monclair, T ;
Costa, E ;
Horcher, E ;
Neuenschwander, S ;
Tomà, P ;
Rizzo, A ;
Michon, J ;
Holmes, K .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) :8483-8489
[10]   The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report [J].
Cohn, Susan L. ;
Pearson, Andrew D. J. ;
London, Wendy B. ;
Monclair, Tom ;
Ambros, Peter F. ;
Brodeur, Garrett M. ;
Faldum, Andreas ;
Hero, Barbara ;
Iehara, Tomoko ;
Machin, David ;
Mosseri, Veronique ;
Simon, Thorsten ;
Garaventa, Alberto ;
Castel, Victoria ;
Matthay, Katherine K. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (02) :289-297